According to previous studies, the upregulation of INHBA mRNA expression occurs after treatment with the methyltransferase inhibitor, 5-aza-2’-deoxycytidine, in esophageal adenocarcinoma and lung adenocarcinoma cell lines. Here, INHBA is linked to lung adenocarcinoma.